Locations:
Search IconSearch

Cancer

Lymphocyte therapy
April 15, 2021/Cancer/Research

New Cell Therapies May Hold Key to Treatment of Advanced and Rare Skin Cancers

Tumor-infiltrating lymphocytes and natural killer cells

650×450-Prostate-Cancer-Klein
April 8, 2021/Cancer

Genomic Testing Can Predict Long-Term Outcomes in Prostate Cancer Patients, Study Finds

How these findings remove some clinical subjectivity, guide management

Chemo
April 6, 2021/Cancer

Pediatric-Inspired Regimen Well Tolerated by Adolescents and Young Adults With Acute Lymphoblastic Leukemia

A deep dive into survival differences between pediatric and adolescent/young adult leukemia patients

Endoluminal Surgery
April 6, 2021/Cancer

Conscious Sedation for Endoluminal Colorectal Procedures a Game-Changer

“It’s better for everyone,” surgeon says.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Prostate cancer
April 5, 2021/Cancer

Prostate Cancer: To Screen or Not To Screen? The Question Is Complicated

Considerations to help guide patients through the decision-making process

PTEN flip-Lerner
March 26, 2021/Cancer/Genomics

Cleveland Clinic Designated PTEN Clinical Center of Excellence

Clinicians and researchers with unique expertise

Nivolumab
March 24, 2021/Cancer/Research

Venous Thromboembolism Common in Cancer Patients Treated with Immunotherapy

An underappreciated immune-related adverse event

Illustration of endometrial cancer
March 4, 2021/Cancer

Primary Cytoreductive Surgery Improves Survival Significantly Compared with Other Types of Treatment

A new study explores survival outcomes based on treatment modality

BackPage 48 of 86Next

Advertisement

Ad